StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie Wholesaler Chargebacks — Beginning Balance by Year

Wholesaler Chargebacks — Beginning Balance ($M) ($M)

AbbVie Wholesaler Chargebacks — Beginning Balance: $1,157M in FY2025, down 1.3% from a year earlier.

Latest, FY2025
1,157
Period ended Dec 31, 2025
Change on a year earlier
-1.3%
1,172 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below

Where the FY2025 figure comes from

“|| Balance as of December 31, 2024 | 7,407 | 5,525 | 1,157”

Source: Form 10-K (abbv-20251231.htm, filed 2026-02-20) ↗

Reported in Form 10-K Item 7 MD&A Rebates & Chargebacks Rollforward.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). AbbVie Wholesaler Chargebacks — Beginning Balance ($M), annual FY2013–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/gtn-chargebacks-beg

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.